# EDGAR Filing Document

**Accession Number:** 0001796898
**File Stem:** 0001796898-23-000024
**Filing Date:** 2023-3
**Character Count:** 42451
**Document Hash:** eaab5941e22276388516e3c10a563993
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001796898-23-000024.hdr.sgml**: 20230307

**ACCESSION NUMBER**: 0001796898-23-000024

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20230101

**FILED AS OF DATE**: 20230307

**DATE AS OF CHANGE**: 20230307

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Maxeon Solar Technologies, Ltd.
- **CENTRAL INDEX KEY:** 0001796898
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** U0
- **FISCAL YEAR END:** 1230

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39368
- **FILM NUMBER:** 23712628

**BUSINESS ADDRESS:**
- **STREET 1:** 8 MARINA BOULEVARD #05-02
- **STREET 2:** MARINA BAY FINANCIAL CENTRE
- **CITY:** MARINA BAY
- **STATE:** U0
- **ZIP:** 018981
- **BUSINESS PHONE:** 408.457.2302

**MAIL ADDRESS:**
- **STREET 1:** 8 MARINA BOULEVARD #05-02
- **STREET 2:** MARINA BAY FINANCIAL CENTRE
- **CITY:** MARINA BAY
- **STATE:** U0
- **ZIP:** 018981

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Maxeon Solar Technologies, Pte. Ltd.
- **DATE OF NAME CHANGE:** 20191213

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM 6-K**

**Report of Foreign Private Issuer** 

**Pursuant to Rule 13a-16 or 15d-16**

**of the Securities Exchange Act of 1934** 

**Date of Report: March 2023** 

**Commission File Number: 001-39368**

**MAXEON SOLAR TECHNOLOGIES, LTD.**

**(Exact Name of registrant as specified in its charter)** 

**8 Marina Boulevard #05-02**

**Marina Bay Financial Centre**

**018981, Singapore**

 **(Address of principal executive office)** 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

------

&nbsp;&nbsp;&nbsp;&nbsp;

**<u>Explanatory Note</u>**

On March 7, 2023 Maxeon Solar Technologies, Ltd. (the "Company"), issued a press release entitled "Maxeon Solar Technologies Announces Fourth Quarter and Fiscal Year 2022 Financial Results." A copy of this press release is furnished as Exhibit 99.1 herewith.

Other than as indicated below, the information in this Form 6-K (including in Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

The U.S. GAAP financial information contained in (i) the condensed consolidated balance sheets, (ii) condensed consolidated statements of operations and (iii) condensed consolidated statements of cash flows, and the other financial information under the headings "Supplementary information affecting GAAP and Non-GAAP results" and "Reconciliation of Non-GAAP Financial Measures", in each case, included in the press release attached as Exhibit 99.1 to this Report on Form 6-K are hereby incorporated by reference into the Company's registration statements on Form F-3 (File No. 333-265253) and (File No. 333-268309) and Form S-8 (File No. 333-241709).

------

&nbsp;&nbsp;&nbsp;&nbsp;

**SIGNATURES** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | MAXEON SOLAR TECHNOLOGIES, LTD.<br>(Registrant) | MAXEON SOLAR TECHNOLOGIES, LTD.<br>(Registrant) |
| March 7, 2023 | By: | /s/ Kai Strohbecke |
|  |  | Kai Strohbecke |
|  |  | Chief Financial Officer |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;

**<u>EXHIBITS</u>**

---

| | |
|:---|:---|
| **Exhibit** | **Title** |
| <u>[99.1](a991-q422.htm)</u> | Press release on fourth quarter and fiscal year 2022 financial results |

---

## Exhibit 99.1

**Exhibit 99.1**

![logo.jpg](logo.jpg)

**Investor Contact:**

Robert Lahey

robert.lahey@maxeon.com

+1 (202) 246-1872

**Media Contact:**

Anna Porta

anna.porta@maxeon.com

+39 345 7706205

**Maxeon Solar Technologies Announces Fourth Quarter and Fiscal Year 2022 Financial Results**

*--Record Gross Profit of $20 million in fourth quarter of 2022--*

*--Guiding Positive Adj. EBITDA in first quarter of 2023--*

**Singapore, March 8, 2023** – Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN) ("Maxeon" or "the Company"), a global leader in solar innovation and channels, today announced its financial results for its fourth quarter and fiscal year ended January 1, 2023.

Maxeon's Chief Executive Officer Bill Mulligan noted, "After more than two years of investment in significant transformation initiatives, Maxeon's financial performance is improving rapidly. The Company's gross profit increased to $20 million in the fourth quarter due to strong operational performance and prudent supply chain management, a record for Maxeon. Next quarter, Maxeon projects further progress leading to positive adjusted EBITDA for the first time since our spin-out. This continued margin improvement is attributable to strong execution by both our manufacturing and sales teams. In our distributed generation (DG) business, pricing is benefiting from continued strength in our European channel with increasing attach rates for Beyond the Panel products, and also in the United States (US) with strong demand from both SunPower as well as through our new Maxeon installer channel which kicked off in January. Our US DG partners indicate significant year-over-year growth for us in 2023, which we attribute in part to our products' popularity in high-cost-of-power markets and sales professionals skilled at selling long-term value."

Mulligan continued "The US utility-scale business is poised for further growth with cumulative bookings now 4.2 gigawatts extending deep into 2025 plus options with advance deposits for an additional 1.5 gigawatts through 2027. Our first 1.8GW of Performance Line manufacturing capacity is on track to reach full output later this year. With the majority of the ramp already completed, we expect improving COGS to drive positive adjusted EBITDA in the current quarter."

**Selected Q4 and Fiscal Year Unaudited Financial Summary**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **(In thousands, except shipments)** | **Fiscal Q4 2022** | **Fiscal Q3 2022** | **Fiscal Q4 2021** | **Fiscal Year 2022** | **Fiscal Year 2021** |
| Shipments, in MW | 734 | 605 | 577 | 2348 | 1956 |
| Revenue | $323503 | $275449 | $221479 | $1060113 | $783279 |
| Gross profit (loss)<sup>(1)</sup> | 20087 | (15747) | (10545) | (47948) | (29014) |
| GAAP Operating expenses | 38038 | 41196 | 35518 | 152346 | 143433 |
| GAAP Net loss attributable to the stockholders<sup>(1)</sup> | (75701) | (44691) | (73332) | (267424) | (254520) |
| Capital expenditures | 7314 | 16110 | 37393 | 63337 | 154194 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Other Financial Data**<sup>(1), (2)</sup> | **Other Financial Data**<sup>(1), (2)</sup> | **Other Financial Data**<sup>(1), (2)</sup> | **Other Financial Data**<sup>(1), (2)</sup> | **Other Financial Data**<sup>(1), (2)</sup> |
| **(In thousands)** | **Fiscal Q4 2022** | **Fiscal Q3 2022** | **Fiscal Q4 2021** | **Fiscal Year 2022** | **Fiscal Year 2021** |
| Non-GAAP Gross profit (loss)<sup>(1)</sup> | $20696 | $(15492) | $(10056) | $(31243) | $(27764) |
| Non-GAAP Operating expenses | 34488 | 34651 | 33423 | 133669 | 129368 |
| Adjusted EBITDA<sup>(1)</sup> | (3712) | (34501) | (32777) | (108636) | (116824) |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> The Company's GAAP and Non-GAAP results were impacted by the effects of certain items. Refer to "*Supplementary information affecting GAAP and Non-GAAP results*" below.

<sup>(2)</sup> The Company's use of Non-GAAP financial information, including a reconciliation to U.S. GAAP, is provided under "Use of Non-GAAP Financial Measures" below.

*Supplementary information affecting GAAP and Non-GAAP results*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Fiscal Year Ended** | **Fiscal Year Ended** |
| **(In thousands)** | **Financial statements item affected** | **January 1, 2023** | **October 2, 2022** | **January 2, 2022** | **January 1, 2023** | **January 2, 2022** |
| Incremental cost of above market polysilicon<sup>(1)</sup> | Cost of revenue | 30 | 603 | 11542 | 11329 | 47188 |
| Loss on ancillary sales of excess polysilicon<sup>(2)</sup> | Cost of revenue |  |  | 2621 | 8328 | 14264 |

---

<sup>(1)</sup> Relates to the difference between our contractual cost for the polysilicon under the long-term fixed supply agreements with our supplier and the price of polysilicon available in the market as derived from publicly available information at the beginning of each quarter, multiplied by the volume of modules sold within the quarter.

<sup>(2)</sup> In order to reduce inventory and improve working capital, we had periodically elected to sell polysilicon inventory procured under the long-term fixed supply agreements in the market at prices below our purchase price, thereby incurring a loss.

**Fiscal Year 2023 and First Quarter 2023 Outlook**

For the first quarter of 2023, the Company anticipates the following results:

---

| | |
|:---|:---|
| **(In millions, except shipments)** | **Outlook** |
| Shipments, in MW | 730 - 770 MW |
| Revenue | $305 - $345 |
| Gross profit | $29 - $39 |
| Non-GAAP gross profit<sup>(1)</sup> | $30 - $40 |
| Operating expenses | $41 ± $2 |
| Non-GAAP operating expenses<sup>(2)</sup> | $37 ± $2 |
| Adjusted EBITDA<sup>(3)</sup> | $10 - $20 |
| Capital expenditures<sup>(4)</sup> | $13 - $17 |

---

For fiscal year 2023, the Company anticipates the following results:

–Revenue to be within a range of $1,350 million to $1,550 million.

–Adjusted EBITDA<sup>(3)</sup> to be within a range of $80 million to $100 million.

*–*Capital expenditures<sup>(4)</sup> to be within a range of $100 million to $120 million.

<sup>(1)</sup> The Company's Non-GAAP gross profit is impacted by the effects of adjusting for stock-based compensation expense.

<sup>(2)</sup> The Company's Non-GAAP operating expenses are impacted by the effects of adjusting for stock-based compensation expense and restructuring charges and fees.

<sup>(3)</sup> The Company cannot provide a reconciliation between its Adjusted EBITDA projection and the most directly comparable GAAP measures without unreasonable efforts because it is unable to predict with reasonable certainty the ultimate outcome of the remeasurement gain or loss of the prepaid forward and the equity in income or losses of our unconsolidated investee.

------

&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(4)</sup> The capital expenditures mainly relate to preparation for capacity expansion for our Maxeon 7 technology, completion of manufacturing capacity for Performance line panels to be sold in the U.S. market, completion of manufacturing capacity for our Maxeon 6 product platform, further developing Maxeon 7 technology and operating a pilot line, as well as various corporate initiatives. The above excludes capital expenditures in connection to the investment plan to deploy a multi-GW factory in the United States to manufacture solar products for both the DG and utility-scale power plant markets.

These anticipated results for fiscal year 2023 and the first quarter of 2023 are preliminary, unaudited and represent the most current information available to management. The Company's business outlook is based on management's current views and estimates with respect to market conditions, production capacity, the uncertainty of the continuing COVID-19 pandemic, and the global economic environment. Please refer to Forward Looking Statements section below. Management's views and estimates are subject to change without notice.

**For more information**

Maxeon's fiscal year 2022 financial results and management commentary can be found on Form 20-F by accessing the Financials & Filings page of the Investor Relations section of Maxeon's website at: https://corp.maxeon.com/investor-relations. The Form 20-F and Company's other filings are also available online from the Securities and Exchange Commission at www.sec.gov.

**Conference Call Details**

The Company will hold a conference call on March 7, 2023, at 5:00 PM U.S. ET / March 8, 2023, at 6:00 AM Singapore Time, to discuss results and provide an update on the business.

To join the live conference call, participants must first register here, where a dial-in number will be provided.

A simultaneous audio-only webcast of the conference call will also be available on Maxeon's website at https://edge.media-server.com/mmc/p/npaoiv87. A webcast replay will be available on Maxeon's website for one year at https://corp.maxeon.com/events-and-presentations<u>.</u>

**About Maxeon Solar Technologies**

Maxeon Solar Technologies Ltd (NASDAQ: MAXN) is Powering Positive Change<sup>TM</sup>. Headquartered in Singapore, Maxeon designs and manufactures Maxeon® and SunPower® brand solar panels, and has sales operations in more than 100 countries, operating under the SunPower brand in certain countries outside the United States. The Company is a leader in solar innovation with access to over 1,000 patents and two best-in-class solar panel product lines. Maxeon products span the global rooftop and solar power plant markets through a network of more than 1,700 trusted partners and distributors. A pioneer in sustainable solar manufacturing, Maxeon leverages a +35-year history in the solar industry and numerous awards for its technology. For more information about how Maxeon is Powering Positive Change<sup>TM</sup> visit us at https://www.maxeon.com/, on LinkedIn and on Twitter.

**Forward-Looking Statements**

This press release contains forward-looking statements within the meaning of the Section 27A of the Securities Act of

1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, but not limited to, statements regarding: (a) our expectations regarding pricing trends, demand and growth projections; (b) potential disruptions to our operations and supply chain that may result from epidemics, natural disasters or military conflicts, including the duration, scope and impact on the demand for our products, market disruptions from the war in Ukraine and the pace of recovery from the COVID-19 pandemic; (c) anticipated product launch timing and our expectations regarding ramp, customer acceptance and demand, upsell and expansion opportunities; (d) our expectations and plans for short- and long-term strategy, including our anticipated areas of focus and investment, market expansion, product and technology focus, and projected growth and profitability; (e) our ability to meet short-term and long-term material cash requirements, our ability to complete an equity or debt offering at favorable terms, if at all, and our overall liquidity, substantial indebtedness and ability to obtain additional financing; (f) our technology outlook, including anticipated fab capacity expansion and utilization and expected ramp and production timelines for the Company's Maxeon 6, next-generation Maxeon 7 and Performance line solar panels, expected cost reductions, and future performance; (g) our strategic goals and plans, including partnership discussions with respect to the Company's next-generation technology, and our relationships with existing customers, suppliers and partners, and our ability to achieve and maintain them; (h) our expectations regarding our future performance and revenues resulting from contracted orders, bookings, backlog, pipelines in our sales channels and feedback from our partners; (i) our projected effective tax rate and changes to the valuation allowance related to our deferred tax assets; and (j) our first quarter and annual fiscal year 2023 guidance, including shipments, revenue, gross profit (loss), non-GAAP gross profit (loss), operating expenses, non-GAAP operating expenses, Adjusted EBITDA, capital expenditures, out-of-market polysilicon cost and related assumptions.

------

&nbsp;&nbsp;&nbsp;&nbsp;

The forward-looking statements can be also identified by terminology such as "may," "projects,""indicate," "expect," "anticipates," "future," "plans," "believes," "estimates," "outlook" and similar statements. Among other things, the quotations from management in this press release and Maxeon's operations and business outlook contain forward-looking statements.

These forward-looking statements are based on our current assumptions, expectations and beliefs and involve substantial risks and uncertainties that may cause results, performance or achievement to materially differ from those expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to a number of risks. The reader should not place undue reliance on these forward-looking statements, as there can be no assurances that the plans, initiatives or expectations upon which they are based will occur. Factors that could cause or contribute to such differences include, but are not limited to: (1) challenges in executing transactions key to our strategic plans, including regulatory and other challenges that may arise; (2) our liquidity, substantial indebtedness, terms and conditions upon which our indebtedness is incurred, and ability to obtain additional financing for our projects, customers and operations; (3) our ability to manage supply chain shortages and cost increases and operating expenses; (4) potential disruptions to our operations and supply chain that may result from damage or destruction of facilities operated by our suppliers, difficulties in hiring or retaining key personnel, epidemics, natural disasters, including impacts of the COVID-19 pandemic, or the war in Ukraine; (5) our ability to manage our key customers and suppliers; (6) the success of our ongoing research and development efforts and our ability to commercialize new products and services, including products and services developed through strategic partnerships; (7) competition in the solar and general energy industry and downward pressure on selling prices and wholesale energy pricing, including impacts of inflation, economic recession and foreign exchange rates upon customer demand; (8) changes in regulation and public policy, including the imposition and applicability of tariffs; (9) our ability to comply with various tax holiday requirements as well as regulatory changes or findings affecting the availability of economic incentives promoting use of solar energy and availability of tax incentives or imposition of tax duties; (10) fluctuations in our operating results and in the foreign currencies in which we operate; (11) appropriately sizing, or delays in expanding our manufacturing capacity and containing manufacturing and logistics difficulties that could arise; (12) unanticipated impact to customer demand and sales schedules due, among other factors, to the spread of COVID-19, the war in Ukraine, economic recession and environmental disasters; (13) challenges managing our acquisitions, joint ventures and partnerships, including our ability to successfully manage acquired assets and supplier relationships; (14) reaction by securities or industry analysts to our quarterly guidance which, in combination with our results of operations or other factors, may cause them to cease publishing research or reports about us, or adversely change their recommendations regarding our ordinary shares, which may negatively impact the market price of our ordinary shares and volume of our stock trading; and (15) unpredictable outcomes resulting from our litigation activities or other disputes. A detailed discussion of these factors and other risks that affect our business is included in filings we make with the Securities and Exchange Commission ("SEC") from time to time, including our most recent report on Form 20-F, particularly under the heading "Risk Factors". Copies of these filings are available online from the SEC at www.sec.gov, or on the SEC Filings section of our Investor Relations website at https://corp.maxeon.com/investor-relations. All forward-looking statements in this press release are based on information currently available to us, and we assume no obligation to update these forward-looking statements in light of new information or future events.

**Use of Non-GAAP Financial Measures**

We present certain non-GAAP measures such as non-GAAP gross profit (loss), non-GAAP operating expenses and earnings before interest, taxes, depreciation and amortization ("EBITDA") adjusted for stock-based compensation, restructuring charges and fees, remeasurement loss (gain) on prepaid forward and physical delivery forward, loss on extinguishment of debt, impairment, equity in losses of unconsolidated investees and related gains and loss related to settlement of price escalation dispute ("Adjusted EBITDA") to supplement our consolidated and combined financial results presented in accordance with GAAP. Non-GAAP gross profit (loss) is defined as gross profit (loss) excluding stock-based compensation and loss related to settlement of price escalation dispute. Non-GAAP operating expenses is defined as operating expenses excluding stock-based compensation and restructuring charges and fees.

We believe that non-GAAP gross profit (loss), non-GAAP operating expenses and Adjusted EBITDA provide greater transparency into management's view and assessment of the Company's ongoing operating performance by removing items management believes are not representative of our continuing operations and may distort our longer-term operating trends. We believe these measures are useful to help enhance the comparability of our results of operations across different reporting periods on a consistent basis and with our competitors, distinct from items that are infrequent or not associated with the Company's core operations as presented above. We also use these non-GAAP measures internally to assess our business, financial performance and current and historical results, as well as for strategic decision-making and forecasting future results. Given our use of non-GAAP measures, we believe that these measures may be important to investors in understanding our operating results as seen through the eyes of management. These non-GAAP measures are neither prepared in accordance with GAAP nor are they intended to be a replacement for GAAP financial data, should be reviewed together with GAAP measures and may be different from non-GAAP measures used by other companies.

As presented in the "Reconciliation of Non-GAAP Financial Measures" section, each of the non-GAAP financial measures excludes one or more of the following items in arriving to the non-GAAP measures:

------

&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Restructuring charges and fees*. We incur restructuring charges and fees related to reorganization plans aimed towards realigning resources consistent with our global strategy and improving its overall operating efficiency and cost structure. Restructuring charges and fees are excluded from non-GAAP operating expenses and Adjusted EBITDA because they are not considered core operating activities. Although we have engaged in restructuring activities and initiatives, past activities have been discrete events based on unique sets of business objectives. As such, management believes that it is appropriate to exclude restructuring charges and fees from our non-GAAP financial measures as they are not reflective of ongoing operating results nor do these charges contribute to a meaningful evaluation of our past operating performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>•</sup> *Remeasurement loss (gain) on prepaid forward and physical delivery forward*. This relates to the mark-to-market fair value remeasurement of privately negotiated prepaid forward and physical delivery transactions. The transactions were entered into in connection with the issuance on July 17, 2020 of the 6.50% Green Convertible Senior Notes due 2025 for an aggregate principal amount of $200.0 million. The prepaid forward is remeasured to fair value at the end of each reporting period, with changes in fair value booked in earnings. The fair value of the prepaid forward is primarily affected by the Company's share price. The physical delivery forward was remeasured to fair value at the end of the Note Valuation Period on September 29, 2020, and was reclassified to equity after remeasurement, and will not be subsequently remeasured. The fair value of the physical delivery forward was primarily affected by the Company's share price. The remeasurement loss (gain) on prepaid forward and physical delivery forward is excluded from Adjusted EBITDA because it is not considered core operating activities. As such, management believes that it is appropriate to exclude these mark-to-market adjustments from our Adjusted EBITDA as they are not reflective of ongoing operating results nor do the loss (gain) contribute to a meaningful evaluation of our past operating performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Loss on extinguishment of debt*. This relates to the loss that arose from the termination of our $50.0 million working capital facility in September 2021 and the expiration of the availability period for draw down of our $75.0 million term loans in August 2021. Loss on debt extinguishment is excluded from Adjusted EBITDA because it is not considered part of core operating activities. Such activities are discrete events based on unique sets of business objectives. As such, management believes that it is appropriate to exclude the loss on extinguishment of debt from our non-GAAP financial measures as it is not reflective of ongoing operating results nor do these charges contribute to a meaningful evaluation of our past operating performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Impairment*. This relates to the impairment of assets recorded by our equity method investee, Huansheng JV. Asset impairment is excluded from our Adjusted EBITDA financial measure as it is non-cash in nature and not reflective of ongoing operating results. As such, management believes that it is appropriate to exclude such charges as they do not contribute to a meaningful evaluation of our past operating performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Equity in losses of unconsolidated investees and related gains.* This relates to the loss on our unconsolidated equity investment Huansheng JV and gains on such investment. This is excluded from our Adjusted EBITDA financial measure as it is non-cash in nature and not reflective of our core operational performance. As such, management believes that it is appropriate to exclude such charges as they do not contribute to a meaningful evaluation of our performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Loss related to settlement of price escalation dispute.* This relates to loss arising from the settlement of price escalation dispute with a polysilicon supplier related to our long-term, firm commitment polysilicon supply agreement. This is excluded from our Adjusted EBITDA financial measure as it is non-recurring and not reflective of ongoing operating results. As such, management believes that it is appropriate to exclude such charges as the loss does not contribute to a meaningful evaluation of our past operating performance.

------

**Reconciliation of Non-GAAP Financial Measures**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Fiscal Year Ended** | **Fiscal Year Ended** |
| **(In thousands)** | **January 1, 2023** | **October 2, 2022** | **January 2, 2022** | **January 1, 2023** | **January 2, 2022** |
| **Gross profit (loss)** | $**20087** | $**(15747)** | $**(10545)** | $**(47948)** | $**(29014)** |
| Stock-based compensation | 609 | 255 | 489 | 1535 | 1250 |
| Loss related to settlement of price escalation dispute |  |  |  | 15170 |  |
| **Non-GAAP Gross profit (loss)** | **20696** | **(15492)** | **(10056)** | **(31243)** | **(27764)** |
| **GAAP Operating expenses** | **38038** | **41196** | **35518** | **152346** | **143433** |
| Stock-based compensation | (2956) | (5918) | (1545) | (13045) | (5981) |
| Restructuring charges and fees | (594) | (627) | (550) | (5632) | (8084) |
| **Non-GAAP Operating expenses** | **34488** | **34651** | **33423** | **133669** | **129368** |
| **GAAP Net loss attributable to the stockholders** | **(75701)** | **(44691)** | **(73332)** | **(267424)** | **(254520)** |
| Interest expense, net | 9307 | 8035 | 6511 | 27812 | 27848 |
| Provision for (benefit from) income taxes | 28030 | 2399 | (1016) | 32191 | 203 |
| Depreciation | 14422 | 13845 | 11930 | 56470 | 41827 |
| Amortization | 57 | 50 | 185 | 272 | 383 |
| EBITDA | (23885) | (20362) | (55722) | (150679) | (184259) |
| Impairment |  |  | 5058 |  | $5058 |
| Stock-based compensation | 3565 | 6173 | 2034 | 14580 | $7231 |
| Loss related to settlement of price escalation dispute |  |  |  | 15170 | $— |
| Restructuring charges (credits) and fees<sup>(1)</sup> | 594 | 627 | (378) | 5632 | $7156 |
| Remeasurement loss (gain) on physical delivery forward and prepaid forward | 17726 | (24521) | 9827 | (2411) | $34468 |
| Equity in (income) losses of unconsolidated investees and related gain | (1712) | 3582 | 6404 | 9072 | $8447 |
| Loss on extinguishment of debt |  |  |  |  | $5075 |
| **Adjusted EBITDA**<sup>(2)</sup> | **(3712)** | **(34501)** | **(32777)** | **(108636)** | $**(116824)** |

---

<sup>(1)</sup> Amount represents restructuring charges and fees related to reorganization plans, excluding accelerated depreciation amounting to $0.9 million included in the depreciation line for the three months ended January 2, 2022 and fiscal year 2021.

<sup>(2)</sup> The Adjusted EBITDA for three months ended January 2, 2022 did not contain an adjustment for equity in losses of unconsolidated investees and related gain on such equity investment. For a reconciliation of Adjusted EBITDA to GAAP Net Loss for the three months ended January 2, 2022, please refer to our Forms 6-K furnished with the SEC on March 24, 2022.

------

&nbsp;&nbsp;&nbsp;&nbsp;

**Reconciliation of Non-GAAP Outlook**

---

| | |
|:---|:---|
| **(In millions)** | **Outlook** |
| **Gross profit** | **$29 - $39** |
| Stock-based compensation | 1 |
| **Non-GAAP gross profit** | **$30 - $40** |
| **Operating expenses** | **$41 ± $2** |
| Stock-based compensation | (4) |
| **Non-GAAP operating expenses** | **$37 ± $2** |

---

**©2023 Maxeon Solar Technologies, Ltd. All rights reserved. MAXEON is a registered trademark of Maxeon Solar Technologies, Ltd. Visit https://corp.maxeon.com/trademarks for more information.**

------

&nbsp;&nbsp;&nbsp;&nbsp;

**MAXEON SOLAR TECHNOLOGIES, LTD.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

**(unaudited)**

**(In thousands, except for shares data)**

---

| | | |
|:---|:---|:---|
| | **As of** | **As of** |
| | **January 1, 2023** | **January 2, 2022** |
| **Assets** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $227442 | $166542 |
| &nbsp;&nbsp;&nbsp;Short-term securities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;76000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— |
| &nbsp;&nbsp;&nbsp;Restricted short-term marketable securities | 968 | 1079 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | 54301 | 39730 |
| &nbsp;&nbsp;&nbsp;Inventories | 303230 | 212820 |
| &nbsp;&nbsp;&nbsp;Advances to suppliers, current portion | 2137 | 51045 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 126971 | 61904 |
| **Total current assets** | $**791049** | $**533120** |
| Property, plant and equipment, net | 380468 | 386630 |
| Operating lease right of use assets | 17844 | 15397 |
| Intangible assets, net | 291 | 420 |
| Advances to suppliers, net of current portion |  | 716 |
| Deferred tax assets | 10348 | 5183 |
| Other long-term assets | 60418 | 115077 |
| **Total assets** | $**1260418** | $**1056543** |
| **Liabilities and Equity** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $247870 | $270475 |
| &nbsp;&nbsp;&nbsp;Accrued liabilities | 135157 | 78680 |
| &nbsp;&nbsp;&nbsp;Contract liabilities, current portion | 139267 | 44059 |
| &nbsp;&nbsp;&nbsp;Short-term debt | 50526 | 25355 |
| &nbsp;&nbsp;&nbsp;Operating lease liabilities, current portion | 3412 | 2467 |
| **Total current liabilities** | $**576232** | $**421036** |
| Long-term debt | 1649 | 213 |
| Contract liabilities, net of current portion | 161678 | 58994 |
| Operating lease liabilities, net of current portion | 15603 | 13464 |
| Convertible debt | 378610 | 145772 |
| Deferred tax liabilities | 14913 | 1150 |
| Other long-term liabilities | 63663 | 61039 |
| **Total liabilities** | $**1212348** | $**701668** |
| Commitments and contingencies |  |  |
| Equity: |  |  |
| &nbsp;&nbsp;&nbsp;Common stock, no par value (45,033,027 and 44,246,603 issued and outstanding as of January 1, 2023 and January 2, 2022, respectively) | $— | $— |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 584808 | 624261 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (520263) | (262961) |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (22108) | (11844) |
| Equity attributable to the Company | 42437 | 349456 |
| &nbsp;&nbsp;&nbsp;Noncontrolling interests | 5633 | 5419 |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| Total equity | 48070 | 354875 |
| **Total liabilities and equity** | $**1260418** | $**1056543** |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;

**MAXEON SOLAR TECHNOLOGIES, LTD.**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

**(unaudited)**

**(In thousands, except per share data)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Fiscal Year Ended** | **Fiscal Year Ended** |
| | **January 1, 2023** | **January 2, 2022** | **January 1, 2023** | **January 2, 2022** |
| Revenue | $323503 | $221479 | $1060113 | $783279 |
| Cost of revenue | 303416 | 232024 | 1108061 | 812293 |
| Gross profit (loss) | 20087 | (10545) | (47948) | (29014) |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Research and development | 11403 | 10700 | 49682 | 46527 |
| &nbsp;&nbsp;&nbsp;Sales, general and administrative | 26132 | 24268 | 100546 | 88822 |
| &nbsp;&nbsp;&nbsp;Restructuring charges | 503 | 550 | 2118 | 8084 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 38038 | 35518 | 152346 | 143433 |
| Operating loss | (17951) | (46063) | (200294) | (172447) |
| Other expense, net |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense, net | (9307) | (6511) | (27812) | (27848) |
| &nbsp;&nbsp;&nbsp;Loss on extinguishment of debt |  |  |  | (5075) |
| &nbsp;&nbsp;&nbsp;Other, net | (22129) | (10574) | 2223 | (33693) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other expense, net | (31436) | (17085) | (25589) | (66616) |
| Loss before income taxes and equity in losses of unconsolidated investees | (49387) | (63148) | (225883) | (239063) |
| &nbsp;&nbsp;&nbsp;(Provision for) benefit from income taxes | (28030) | 1016 | (32191) | (203) |
| &nbsp;&nbsp;&nbsp;Equity in income (losses) of unconsolidated investees | 1712 | (11462) | (9072) | (16480) |
| Net loss | (75705) | (73594) | (267146) | (255746) |
| &nbsp;&nbsp;&nbsp;Net loss (income) attributable to noncontrolling interests | 4 | 262 | (278) | 1226 |
| Net loss attributable to the stockholders | $(75701) | $(73332) | $(267424) | $(254520) |
| Net loss per share attributable to stockholders: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic and diluted | $(1.84) | $(1.81) | $(6.54) | $(6.79) |
| Weighted average shares used to compute net loss per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic and diluted | 41227 | 40444 | 40920 | 37457 |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;

**MAXEON SOLAR TECHNOLOGIES, LTD.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(unaudited)**

**(In thousands)**

---

| | | |
|:---|:---|:---|
| | **Fiscal Year Ended** | **Fiscal Year Ended** |
| | **January 1, 2023** | **January 2, 2022** |
| **Cash flows from operating activities** | | |
| Net loss | $(267146) | $(255746) |
| Adjustments to reconcile net loss to net cash used in operating activities |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 56219 | 42210 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 14580 | 7231 |
| &nbsp;&nbsp;&nbsp;Non-cash interest expense | 7078 | 13361 |
| &nbsp;&nbsp;&nbsp;Equity in losses of unconsolidated investees | 9072 | 16480 |
| &nbsp;&nbsp;&nbsp;Gain from dilution of interest in joint venture |  | (2975) |
| &nbsp;&nbsp;&nbsp;Loss on retirement of property, plant and equipment | 243 | 2442 |
| &nbsp;&nbsp;&nbsp;Loss on impairment of property, plant and equipment | 417 |  |
| &nbsp;&nbsp;&nbsp;Loss on debt extinguishment |  | 5075 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | 8598 | 5587 |
| &nbsp;&nbsp;&nbsp;Remeasurement (gain) loss on prepaid forward | (2411) | 34468 |
| &nbsp;&nbsp;&nbsp;Reserves (utilization) for excess or obsolete inventories | 16342 | (319) |
| &nbsp;&nbsp;&nbsp;Other, net | 1607 | (1765) |
| &nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (15332) | 38268 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (106622) | (43174) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other assets | (35685) | (20529) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 3192 | 2449 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advances to suppliers | 49624 | 41147 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other accrued liabilities | 70567 | 41098 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contract liabilities | 195650 | 72488 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | (2556) | (2662) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) operating activities | 3437 | (4866) |
| **Cash flows from investing activities** |  |  |
| &nbsp;&nbsp;&nbsp;Purchases of property, plant and equipment | (63337) | (154194) |
| &nbsp;&nbsp;&nbsp;Proceeds from disposal of restricted short-term marketable securities | 958 | 1318 |
| &nbsp;&nbsp;&nbsp;Purchase of restricted short-term marketable securities | (968) | (1094) |
| &nbsp;&nbsp;&nbsp;Purchase of short-term securities | (76000) |  |
| &nbsp;&nbsp;&nbsp;Proceeds from (cash paid for) disposal of property, plant and equipment | 189 | (417) |
| &nbsp;&nbsp;&nbsp;Purchases of intangibles | (143) | (61) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (139301) | (154448) |
| **Cash flows from financing activities** |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from debt | 258426 | 170311 |
| &nbsp;&nbsp;&nbsp;Repayment of debt | (233138) | (193237) |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| | **Fiscal Year Ended** | **Fiscal Year Ended** |
| | **January 1, 2023** | **January 2, 2022** |
| &nbsp;&nbsp;&nbsp;Payment for tax withholding obligations for issuance of common stock upon vesting of restricted stock units | (257) | (4245) |
| &nbsp;&nbsp;&nbsp;Net proceeds from issuance of convertible debt | 187232 |  |
| &nbsp;&nbsp;&nbsp;Net proceeds from issuance of common stock |  | 169684 |
| &nbsp;&nbsp;&nbsp;Distribution to noncontrolling interest | (64) |  |
| &nbsp;&nbsp;&nbsp;Repayment of finance lease obligations and other debt | (725) | (705) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 211474 | 141808 |
| Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents | 119 | 166 |
| Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents | 75729 | (17340) |
| Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period | 192232 | 209572 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents, end of period | $267961 | $192232 |
| **Non-cash transactions** |  |  |
| &nbsp;&nbsp;&nbsp;Property, plant and equipment purchases funded by liabilities | $35264 | $58562 |
| &nbsp;&nbsp;&nbsp;Right-of-use assets obtained in exchange for lease obligations | 5639 | 5029 |
| &nbsp;&nbsp;&nbsp;Cost from issuance of common stock paid in shares |  | 1078 |
| &nbsp;&nbsp;&nbsp;Property, plant and equipment obtained through capital lease | 2127 |  |

---

The following table reconciles our cash and cash equivalents and restricted cash and restricted cash equivalents reported on our Condensed Consolidated Balance Sheets and the cash, cash equivalents, restricted cash and restricted cash equivalents reported on our Condensed Consolidated Statements of Cash Flows as of January 1, 2023 and January 2, 2022:

---

| | | |
|:---|:---|:---|
| **(In thousands)** | **January 1, 2023** | **January 2, 2022** |
| Cash and cash equivalents | $227442 | $166542 |
| Restricted cash and restricted cash equivalents, current portion, included in prepaid expenses and other current assets | 37974 | 1661 |
| Restricted cash and restricted cash equivalents, net of current portion, included in other long-term assets | 2545 | 24029 |
| Total cash, cash equivalents, restricted cash and restricted cash equivalents shown in Condensed Consolidated Statements of Cash Flows | $267961 | $192232 |

---

<br>